Improving Effect of the Acute Administration of Dietary Fiber-Enriched Cereals on Blood Glucose Levels and Gut Hormone Secretion

Journal of Korean Medical Science
Eun Ky KimYoung Min Cho

Abstract

Dietary fiber improves hyperglycemia in patients with type 2 diabetes through its physicochemical properties and possible modulation of gut hormone secretion, such as glucagon-like peptide 1 (GLP-1). We assessed the effect of dietary fiber-enriched cereal flakes (DC) on postprandial hyperglycemia and gut hormone secretion in patients with type 2 diabetes. Thirteen participants ate isocaloric meals based on either DC or conventional cereal flakes (CC) in a crossover design. DC or CC was provided for dinner, night snack on day 1 and breakfast on day 2, followed by a high-fat lunch. On day 2, the levels of plasma glucose, GLP-1, glucose-dependent insulinotropic polypeptide (GIP), and insulin were measured. Compared to CC, DC intake exhibited a lower post-breakfast 2-hours glucose level (198.5±12.8 vs. 245.9±15.2 mg/dL, P<0.05) and a lower incremental peak of glucose from baseline (101.8±9.1 vs. 140.3±14.3 mg/dL, P<0.001). The incremental area under the curve (iAUC) of glucose after breakfast was lower with DC than with CC (P<0.001). However, there were no differences in the plasma insulin, glucagon, GLP-1, and GIP levels. In conclusion, acute administration of DC attenuates postprandial hyperglycemia without any significant change...Continue Reading

References

May 27, 1978·British Medical Journal·D J JenkinsK G Alberti
Sep 1, 1996·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·J E Gerich
Jul 10, 1999·Journal of the American College of Cardiology·H KawanoH Yasue
Feb 15, 2001·Archives of Internal Medicine·UNKNOWN DECODE Study Group, the European Diabetes Epidemiology Group.
May 4, 2002·JAMA : the Journal of the American Medical Association·David S Ludwig
Sep 6, 2005·Biochemical and Biophysical Research Communications·Toshihiko ShiraiwaYoshimitsu Yamasaki
Sep 18, 2008·American Journal of Physiology. Endocrinology and Metabolism·June ZhouMichael J Keenan
Feb 5, 2010·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Joshua Tarini, Thomas M S Wolever
Jun 28, 2011·Lancet·Abd A TahraniAnthony H Barnett
Jul 21, 2012·PloS One·Caroline L BodinhamM Denise Robertson
Sep 14, 2012·Nature·Valentina Tremaroli, Fredrik Bäckhed
Dec 18, 2012·Expert Opinion on Drug Safety·Stephanie Aleskow SteinStephen N Davis
Mar 20, 2013·The British Journal of Nutrition·Caroline L BodinhamM Denise Robertson
Aug 2, 2013·Diabetes Care·Ralph A DeFronzoMuhammad Abdul-Ghani
Nov 20, 2013·Annual Review of Physiology·Young Min ChoTimothy J Kieffer

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay

Clinical Trials Mentioned

NCT01997281

Software Mentioned

Prism GraphPad

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.